LNWTC
RMD icon

Laird Norton Wetherby Trust Company’s ResMed RMD Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
5,695
-242
-4% -$50.2K 0.02% 486
2026
Q1 		$1.33M Sell
5,937
-29
-0.5% -$7.23K 0.03% 411
2025
Q4 		$1.44M Buy
+5,966
New +$1.53M 0.03% 400

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Laird Norton Wetherby Trust Company's RMD Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its ResMed (RMD) stake by 4.1% in Q2 2026, selling an estimated $50.2K and leaving 5,695 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #486.

Laird Norton Wetherby Trust Company first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q4 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 5,695 shares of ResMed worth $1.11M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 242 ResMed shares in Q2 2026, an estimated $50.2K.
  • ResMed made up 0.02% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #486 holding.
  • Laird Norton Wetherby Trust Company first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's ResMed position peaked at $1.44M in Q4 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.